The WHO's new toolkit on scaling health innovations hides a harsh truth: this isn't about grassroots change. It’s about standardization for profit.
Are wellness patches the future of health or a dangerous placebo? We expose the real winners profiting from your stress and libido woes.
The hiring of Joshua Robbins by Crowell isn't just a personnel move; it's a strategic declaration in the escalating **healthcare litigation** landscape.
The BHF's massive data science investment isn't just about saving hearts; it's about who owns the future of **cardiovascular health data**.
The FDA's Digital Health COE isn't just about innovation; it's a quiet power play shaping the future of digital health regulation.
Forget the five 'global health wins' for 2025. We analyze the hidden costs and who truly profits from these celebrated medical milestones.
The mass departure of key FDA digital health leaders signals a regulatory vacuum. Discover the hidden power shift in digital health innovation.
The FDA's Digital Health Center of Excellence sounds benign, but it signals a massive, unaddressed shift in **digital health regulation** and **telemedicine adoption**.
Trump's move against state AI laws isn't about patient safety; it's a regulatory land grab that benefits Big Tech and stalls crucial health AI adoption.
New IBD pregnancy guidelines promise safety, but we analyze the real winners and losers in this medical shift, focusing on optimizing **IBD treatment during pregnancy**.
Why a simple singalong in Suffolk signals a massive shift in public health funding away from pharma and towards community.